Sionna Therapeutics, Inc. (SION) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SION currently has 44.1M outstanding shares. with moderate dilution risk from 17.1M authorized shares representing 38.9% potential dilution. The company has not diluted shareholders through share issuances in the past 2 years, which is positive for existing holders.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Aug 11, 2025 |
10-Q filing | 44.1M shares outstanding |
44M | 17M |
| May 12, 2025 |
10-Q filing | 44.1M shares outstanding |
44M | 17M |
| Feb 03, 2025 |
S-1/A filing: The company intends to use the net proceeds from this offering, together with our existing cash, cash equivalents and investments in marketable securities, for clinical trials, research and development activities, and working capital and other general corporate purposes. |
N/A | 17M |
| Jan 17, 2025 |
S-1 filing: S-1 filing for an initial public offering of common stock. |
N/A | 0 |